Trial intelligence / Profile preview

Early Diuresis with Furosemide After Colorectal Surgery

NCT02351934Phase 4Completed

Sponsor
Mayo Clinic
Start
Feb 2015
Primary completion
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of furosemide in Colorectal disease, sponsored by Mayo Clinic. Primary endpoint: Length of Hospital Stay at 7 days. Started Feb 2015; status: completed.

02

Drugs

furosemide
03

Conditions

Colorectal disease

Beyond the preview

Go deeper on NCT02351934.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02351934.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call